| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,378 | 4,877 | 6,160 | 7,726 | | Cost of Revenue | 2,834 | 837 | 824 | 691 | | | Gross Profit | 5,544 | 4,040 | 5,336 | 7,035 | | | Operating Expenses | | Research Development | 7,598 | 7,866 | 9,903 | 8,456 | | Selling General and Administrative | 3,554 | 3,777 | 4,257 | 3,684 | | Non Recurring |
-
|
-
|
-
| 13,480 | | Others |
-
|
-
|
-
| 13 | | | | Total Operating Expenses |
-
|
-
|
-
| 25,633 | | | | Operating Income or Loss | (5,608) | (7,603) | (8,824) | (18,598) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 82 | 106 | 179 | 262 | | Earnings Before Interest And Taxes | (5,526) | (7,497) | (8,645) | (18,336) | | Interest Expense | 9 | 11 | 11 | 16 | | Income Before Tax | (5,535) | (7,508) | (8,656) | (18,352) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,535) | (7,508) | (8,656) | (18,352) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,535) | (7,508) | (8,656) | (18,352) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,535) | ($7,508) | ($8,656) | ($18,352) |
|
0.31% Nasdaq 
0.05%
Income Statement
